Health ❯Healthcare ❯Pharmaceuticals

Clinical Trials

Market Analysis Investments Patient Safety Cardiovascular Health Cardiology Medical Research Obesity Treatment Obesity Epidemic Apple Clinical Research

Mixed Phase 3 Outcomes Cloud Future of Regeneron and Sanofi’s COPD Candidate Itepekimab

Regeneron plans to consult regulators on next steps for its experimental COPD therapy developed with Sanofi

FDA Halts Rocket’s RP-A501 Gene Therapy for Danon Disease After Patient’s Death

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies

Single-Dose Flu Drug Proven to Reduce Household Transmission by 30%

Leqembi Approved by European Regulators for Early-Stage Alzheimer's Treatment

Eli Lilly’s Lepodisiran Achieves 94% Reduction in Genetic Heart Disease Risk Factor in Phase 2 Trial

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

FDA to Decide on First Twice-Yearly HIV Prevention Shot by June

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

Study Links Common Medications to Reduced Dementia Risk